This COVID-19 roundup includes coverage of the FDA’s amendment to its emergency use authorization of the Pfizer-BioNTech booster for pediatric patients, acute myocardial infection deaths rose during omicron...
In a new study presented at CROI 2023, researchers examined how depression and anxiety in individuals with HIV impacts the risk of incident acute myocardial infarction in this patient population.
This COVID-19 roundup includes coverage of the FDA’s recent approval of bivalent booster vaccines for younger age groups, the use of COVID-19 PrEP and associated risk for the virus, an increase of...
The ACC and AHA recently updated the guideline for diagnosing and distinguishing various causes of chest pain in patients to further prevent and treat cardiovascular diseases.
Previous research has suggested that heat exposure may increase the risk of acute myocardial infarction. In this study, researchers examined the impact of certain medication usage on the relationship...
Newer antiretroviral therapies exert adverse cardiovascular effects. Therefore, monitoring rates of myocardial infarction by HIV status is critical. In a recent study, researchers examined the national...
Prior studies have shown an inverse relationship between some cardiovascular disease risk factors and the risk of Parkinson disease. To better understand the relationship between Parkinson disease,...
A recent survey of individuals who have had a myocardial infarction revealed that they do not understand the role of cholesterol in the risk for subsequent CV event and may not be asking the right questions...
Although current understanding of ischemic heart disease is that it is “multifactorial with predisposing modifiable and non-modifiable risk factors,” previous research has suggested that external factors...
